Produs

Nebivolol-BP

No image

Nebivolol-BP

Tablets
Trade name
Nebivolol-BP
Active ingridient
Nebivololum
Descritpion and Composition
Nebivolol 5 mg tablets are a medication used to treat high blood pressure (hypertension) and mild to moderate stable chronic heart failure in patients aged 70 and older.

The active substance is nebivolol, a selective beta-blocker that dilates blood vessels (vasodilator).

Each tablet contains:

5 mg of nebivolol as nebivolol hydrochloride 5.45 mg
Lactose monohydrate
Magnesium stearate
Colloidal anhydrous silica dioxide
Sodium croscarmellose
Macrogol 6000
Indications:

High blood pressure
Mild to moderate stable chronic heart failure in patients aged 70 and older
Recommended dose:

High blood pressure: one 5 mg tablet per day, preferably taken at the same time each day. In elderly patients and those with kidney conditions, treatment starts with a lower dose, typically 2.5 mg (half a tablet) per day.
Stable chronic heart failure: the dose is individually adjusted based on the severity of the disease and the patient's response to treatment.
PIL
IMPORTANT NOTE

11111

Due to the increasing reports of fraud using the Balkan Pharmaceuticals trademark, we inform you that:

  1. The ONLY official website of the company is https://balkanpharmaceuticals.com/
  2. Balkan Pharmaceuticals does NOT sell products through online stores and e-mails
  3. Balkan Pharmaceuticals does NOT ship packages and does NOT request payments through Western Union, MoneyGram or other international transfer systems (SWIFT, BTC, Crypto currencies) 
  4. All employees at Balkan Pharmaceuticals exclusively use corporate email addresses with domain @balkanpharmaceuticals.com. Please check this when responding to e-mails. Any request to make contact through other addresses is an attempt of fraud!
  5. We recommend that you learn about the latest methods of protection of Balkan Pharmaceuticals products, as well as verify the authenticity of our products, via https://b-p.md/

The health of our patience is our type priority.